Sanofi Says Evidence Doesn't Justify Verdict In Patent Suit
Sanofi-Aventis and Regeneron Pharmaceuticals Inc. pushed again Thursday for a Delaware federal judge to rule that the claims of two Amgen Inc. patents for a cholesterol drug were overbroad and insufficiently...To view the full article, register now.
Already a subscriber? Click here to view full article